Genetics of neonatal onset epilepsies: An overview

Milh, 2016, Severe neonatal seizures: from molecular diagnosis to precision therapy?, Rev Neurol, 172, 171, 10.1016/j.neurol.2016.02.005 Beal, 2012, Early-onset epileptic encephalopathies: ohtahara syndrome and early myoclonic encephalopathy, Pediatr Neurol, 47, 317, 10.1016/j.pediatrneurol.2012.06.002 Auvin, 2016, Current understanding and neurobiology of epileptic encephalopathies, Neurobiol Dis, 92, 72, 10.1016/j.nbd.2016.03.007 Lombroso, 1990, Early myoclonic encephalopathy, early infantile epileptic encephalopathy, and benign and severe infantile myoclonic epilepsies: a critical review and personal contributions, J Clin Neurophysiol, 7, 380, 10.1097/00004691-199007000-00005 Olson, 2017, Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression, Ann Neurol, 81, 419, 10.1002/ana.24883 Weckhuysen, 2012, KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy, Ann Neurol, 71, 15, 10.1002/ana.22644 Milh, 2013, Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2, Orphanet J Rare Dis, 8, 80, 10.1186/1750-1172-8-80 Orhan, 2014, Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy, Ann Neurol, 75, 382, 10.1002/ana.24080 Miceli, 2015, Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits, J Neurosci, 35, 3782, 10.1523/JNEUROSCI.4423-14.2015 Devaux, 2016, A Kv7.2 mutation associated with early onset epileptic encephalopathy with suppression-burst enhances Kv7/M channel activity, Epilepsia, 57, e87, 10.1111/epi.13366 Abidi, 2015, A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels, Neurobiol Dis, 80, 80, 10.1016/j.nbd.2015.04.017 Pisano, 2015, Early and effective treatment of KCNQ2 encephalopathy, Epilepsia, 56, 685, 10.1111/epi.12984 Saitsu, 2008, De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy, Nat Genet, 40, 782, 10.1038/ng.150 Saitsu, 2012, Association of genomic deletions in the STXBP1 gene with Ohtahara Syndrome, Clin Genet, 81, 399, 10.1111/j.1399-0004.2011.01733.x Saitsu, 2010, STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern, Epilepsia, 51, 2397, 10.1111/j.1528-1167.2010.02728.x Milh, 2011, Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations, Epilepsia, 52, 1828, 10.1111/j.1528-1167.2011.03181.x Stamberger, 2016, STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy, Neurology, 86, 954, 10.1212/WNL.0000000000002457 Deprez, 2010, Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations, Neurology, 75, 1159, 10.1212/WNL.0b013e3181f4d7bf Wolff, 2017, Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders, Brain, 140, 1316, 10.1093/brain/awx054 Kato, 2007, A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara Syndrome), Am J Hum Genet, 81, 361, 10.1086/518903 Giordano, 2010, Familial Ohtahara syndrome due to a novel ARX gene mutation, Am J Med Genet A, 152A, 3133, 10.1002/ajmg.a.33701 Fullston, 2010, Ohtahara syndrome in a family with an ARX protein truncation mutation (c.81C>G/p.Y27X), Eur J Hum Genet, 18, 157, 10.1038/ejhg.2009.139 Molinari, 2005, Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy, Am J Hum Genet, 76, 334, 10.1086/427564 Goubert, 2017, Inhibition of the mitochondrial glutamate carrier SLC25A22 in astrocytes leads to intracellular glutamate accumulation, Front Cellular Neurosci, 11, 149, 10.3389/fncel.2017.00149 Plecko, 2013, Pyridoxine and pyridoxalphosphate-dependent epilepsies, Handbook Clin Neurol, 113, 1811, 10.1016/B978-0-444-59565-2.00050-2 Veeramah, 2012, De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP, Am J Hum Genet, 90, 502, 10.1016/j.ajhg.2012.01.006 Larsen, 2015, The phenotypic spectrum of SCN8A encephalopathy, Neurology, 84, 480, 10.1212/WNL.0000000000001211 Wagnon, 2015, Recurrent and non-recurrent mutations of SCN8A in epileptic encephalopathy, Front Neurol, 6, 104, 10.3389/fneur.2015.00104 Barcia, 2012, De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy, Nat Genet, 44, 1255, 10.1038/ng.2441 Abdelnour, 2018, Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature, Seizure, 55, 1, 10.1016/j.seizure.2017.11.017 Mullen, 2018, Precision therapy for epilepsy due to KCNT1 mutations: a randomized trial of oral quinidine, Neurology, 90, e67, 10.1212/WNL.0000000000004769 Dilena, 2018, Early treatment with quinidine in 2 patients with epilepsy of infancy with migrating focal seizures (EIMFS) due to gain-of-function KCNT1 mutations: functional studies, clinical responses, and critical issues for personalized therapy, Neurotherapeutics, 15, 1112, 10.1007/s13311-018-0657-9 Mikati, 2015, Quinidine in the treatment of KCNT1-positive epilepsies, Ann Neurol, 78, 995, 10.1002/ana.24520 Balestrini, 2016, TBC1D24 genotype-phenotype correlation: epilepsies and other neurologic features, Neurology, 87, 77, 10.1212/WNL.0000000000002807 Campeau, 2014, The genetic basis of DOORS syndrome: an exome-sequencing study, Lancet Neurol, 13, 44, 10.1016/S1474-4422(13)70265-5 Milh, 2013, Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy, Hum Mut, 34, 869, 10.1002/humu.22318 Falace, 2010, TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy, Am J Hum Genet, 87, 365, 10.1016/j.ajhg.2010.07.020 Swanson, 1998, Identification and characterization of the human ortholog of rat STXBP1, a protein implicated in vesicle trafficking and neurotransmitter release, Genomics, 48, 373, 10.1006/geno.1997.5202 Di Meglio, 1998, Epileptic patients with de novo STXBP1 mutations: key clinical features based on 24 cases, Epilepsia, 56, 1931, 10.1111/epi.13214